Treatment adherence and 6-mercaptopurine metabolites.
Gaynon
Paul S
PS
Children's Hospital Los Angeles, University of Southern California, Los Angeles, California 90027, USA. pgaynon@chla.usc.edu
D000293:Adolescent; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000493:pharmacokinetics*; D002648:Child; D016000:Cluster Analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D015999:Multivariate Analysis; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D012008:Recurrence; D012307:Risk Factors; D017211:Treatment Failure
D000964:Antimetabolites, Antineoplastic; D015122:Mercaptopurine